FDA Approves Generic Versions of Suboxone

The Food and Drug Administration has informed a British pharmaceutical company that it will not stop other drug makers from producing generic versions of Suboxone tablets, one of its top selling products. The move is a serious blow to Reckitt Benckiser’s efforts to maintain its monopoly of Suboxone, which generates sales of about $1.5 billion…